About us

Karveel Pharmaceuticals was founded in November 2014 by a team of academic researchers from Utrecht University along with a group of experienced Dutch biotech entrepreneurs. The Synamp board of directors consists of: Dr. Nathaniel Martin (PhD), Dr. Timo Koopmans (PhD), and Laurens Kleijn (MSc). Supervisory board members include: Dr. Ronald Brus (MD), Johan Kleyn (LLM), and Dr. Pieter Strijkert (PhD).